Pharmaceuticals and Ambulatory Surgery Centers. Tom Simpleman

Size: px
Start display at page:

Download "Pharmaceuticals and Ambulatory Surgery Centers. Tom Simpleman"

Transcription

1 Pharmaceuticals and Ambulatory Surgery Centers Tom Simpleman Consultant Pharmacist 2014 Rocky Mountain Ambulatory Surgery Center Educational Conference April 10, 2014

2 Pharmaceuticals and Ambulatory Surgery Centers Tom Simpleman Registered Pharmacist Board Certified Geriatric Pharmacist Fellow in the American Society of Consultant Pharmacists Certified Professional in Healthcare Quality Consultant Pharmacist Pharmaceuticals and Ambulatory Surgery Centers Review expectations, current findings from CMS DEA Colorado Board of Pharmacy USP 797 CDC One time One patient No fractionating Single Dose Vials Immediate use 1 hour Multiple Dose Vial Joint Commission Multi-dose vials are to be discarded 28 days after first use unless the manufacturer specifies otherwise (shorter or longer). Manufacturers are only required by law to test the effectiveness of the bacteriostatic agent used in the multi-dose vial for a period of 28 days. Revised expiration date or BUD USP 797 Multiple Dose Vial CMS I. Multi-dose vials are dated when they are first opened and discarded within 28 days unless the manufacturer specifies a different (shorter or longer) date for that opened vial. Note: This is different from the expiration date for the vial. The multi-dose vial can be dated with either the date opened or the discard date as per ASC policies and procedures, so long as it is clear what the date represents and the same policy is used consistently throughout the ASC Multiple Dose Vial CMS J. Multi-dose medications used for more than one patient are stored and accessed away from the immediate areas where direct patient contact occurs.

3 Multiple Dose Vial Multipledose Vial CDC USP 797 If the vial is labeled as a multidose vial or container then the dating should not exceed 28 days UNLESS the manufacturer has data to support longer dating. Centers for Disease and Control (CDC) Multi-dose vials typically contain an antimicrobial preservative to help prevent the growth of bacteria. The preservative has no effect on viruses and does not protect against contamination when healthcare personnel fail to follow safe injection practices Should be dedicated to a single patient whenever possible. If a MDV must be used for more than one patient, they should not be kept or accessed in the immediate patient treatment area. CDC Multi-dose vials Safe Practices for Medical Injections Q&A Large outbreaks in ASCs HBV and HCV Private Medical Practice Pain Clinic Endoscopy Clinic Hematology/oncology clinic CDC Primary Breaches Reinsertion of used needles/syringes into Multiple-dose Vials Single needle/syringe for IV drug to multiple patients CDC Outbreak Study Prevention Prevention prefer SDV vs. MDV CDC Outbreak Study Survey US healthcare workers Use same needle/syringe on multiple patients 1-3% Preparation of in same workspace where needle/syringes were dismantled?

4 CDC Outbreak Study Deficiencies identified in ASCs Lack of oversight of personnel Failure to follow-up on reported breaches in infection control Ensure workers understand and adhere to principles of infection control and aseptic technique Reinforce in training programs in incorporate into policies Monitor for adherence Multipledose Vial Centers for Disease and Control (CDC) Prevent inadvertent contamination Direct or indirect contact Contaminated surfaces or equipment CDC Multi-dose vials Safe Practices for Medical Injections Q&A Multipledose Vial Centers for Disease and Control (CDC) If vial enters immediate patient treatment area Dedicate to that patient only Discard after use CDC Multi-dose vials Safe Practices for Medical Injections Q&A Multipledose Vial CDC recommendations DEA Centers for Disease and Control (CDC) Immediate patient treatment area Patient rooms or bays and operating rooms CDC Multi-dose vials Safe Practices for Medical Injections Q&A Do not use bags or bottles of intravenous solution as a common source of supply for multiple patients Do not keep Multidose vials in immediate patient treatment area and store in accordance with manufacturer s recommendations CDC Practices to prevent transmission of infections to patients Bookeeping 222 forms Guide to show how to complete Store securely POA responsibilities When YOU receive a form (re-distributor)

5 DEA DEA DEA CSOS Controlled Substance Ordering System Diversion Occasional misplaced Track Significant amount Suspected controlled drug diversion Report Report ANY diversion to Colorado State Ephedrine Propofol Colorado Regulations Compounding Pharmacies Compounding Compounding Pharmacies Casual Sale Betamethasone suspension injection and a triamcinolone acetonide suspension injection challenges Prescriber Pharmacy - Patient Betamethasone suspension Triamcinolone Acetonide suspension Difficult to Sterilize Autoclave As temperature increases, some drug goes into solution Supersaturated solution starts crystallizing out» Ultrasound during cooling

6 Compounded Betamethasone suspension Triamcinolone Acetonide suspension Autoclaving Verify parameters Not verified and documented All vials may not be sterilize Verify time of sterilization begins after proper pressure and temperature Colorado Regulations Other Outlet Protocols Changes approved by board of pharmacy prior to implementation Detailed record keeping Inventory, controlled drugs, storage, dispensing Medical Waste Rules have been in place DEA trumps EPA Dan Goetz program Friday Earth friendly ingredients Closely replicate the human stomach function. Breaks down unwanted medications Non-digestible liquid Disposed of similar to common home garbage. Medical Waste Drug Buster Medical Waste Individuals can take unused drugs to various locations. Survey Challenges Expired drugs Anesthesia cart Cor Cart Any Kits Clean ports Infection control

7 IV solutions in boxes not on the floor IV solution hanging with no label, time opened not marked Warm IV solutions in blanket warmer no date Unmarked pre-drawn syringe Glucose meter date opened, verify operation per manufacturer guidelines or facility policy Occurrence reporting line Any non-explainable missing drug Call the health department for all incidents How people act when drugs are diverted Run PYXIS reports on a regular basis Report by the close of the next business day Expired meds Is the order cosigned Within the proper time period Crash cart Expiration dates Diverted drugs Deliberate Intended for the patient Did the patient report non relief 5 days to investigate Report trough the portal Assign tasks to be accomplished every day Verify the job gets done

8 References CDC Safe injection Practices to prevent transmission of infections to patients CDC Multi-dose vials Safe Practices for Medical Injections Q&A RxShortages References RxShortages References Epocrates THE FAWKS COMPANY Tom Simpleman Consultant Pharmacist Pharmaceuticals and Ambulatory Surgery Centers Q & A THE FAWKS COMPANY Tom Simpleman Consultant Pharmacist tsimpleman@fawks.com

9 THE FAWKS COMPANY Consulting is our profession Not a part time job

Injection Safety. Alana Cilwick, MPH. Injection Safety Coordinator

Injection Safety. Alana Cilwick, MPH. Injection Safety Coordinator Injection Safety Alana Cilwick, MPH Injection Safety Coordinator 303-692-2727 alana.cilwick@state.co.us Objectives Demonstrate the importance of safe injection practices Define what constitutes a safe

More information

Injections Without Infections:

Injections Without Infections: Injections Without Infections: Basic Patient Safety Joseph Perz, DrPH Team Leader, Ambulatory and Long-Term Care Prevention and Response Branch Division of Healthcare Quality Promotion Centers for Disease

More information

SAFE INJECTION PRACTICES. Barbara J Connell MS,MT(ASCP)SH VP Clinical Services Medline Industries, Inc.

SAFE INJECTION PRACTICES. Barbara J Connell MS,MT(ASCP)SH VP Clinical Services Medline Industries, Inc. SAFE INJECTION PRACTICES Barbara J Connell MS,MT(ASCP)SH VP Clinical Services Medline Industries, Inc. DISCLOSURES»Employee of Medline Industries, Inc.»Opinions expressed are my own and not necessarily

More information

Injection Safety: Every Provider s Responsibility! Patsy Kelso, PhD State Epidemiologist for Infectious Disease

Injection Safety: Every Provider s Responsibility! Patsy Kelso, PhD State Epidemiologist for Infectious Disease Injection Safety: Every Provider s Responsibility! Patsy Kelso, PhD State Epidemiologist for Infectious Disease Transmission of Hepatitis B and C Viruses in Outpatient Settings MMWR 2003 52:901 Endoscopy

More information

3/2/2018. Christopher M. Dembny R.Ph. Dembny Pharmacy Consultants LLC Learning Objectives. Rule Compliance is Stimulating

3/2/2018. Christopher M. Dembny R.Ph. Dembny Pharmacy Consultants LLC Learning Objectives. Rule Compliance is Stimulating Christopher M. Dembny R.Ph. Dembny Pharmacy Consultants LLC cdembny2@gmail.com Learning Objectives Rule Compliance is Stimulating 1 Biography 2 3 This is a broad and confusing issue for many centers. Information

More information

247 CMR BOARD OF REGISTRATION IN PHARMACY

247 CMR BOARD OF REGISTRATION IN PHARMACY 247 CMR 18.00: NON-STERILE COMPOUNDING Section 18.01: Authority and Purpose 18.02: Non-Sterile Compounding Process 18.03: Non-Sterile Compounding Facility 18.04: Non-Sterile Compounding Equipment 18.05:

More information

Script for Podcast on Injection Safety

Script for Podcast on Injection Safety Script for Podcast on Injection Safety MB: Hi, I m Mary Beth Wenger, of the New York One & Only Campaign. New York is a partner state in the national One & Only Campaign which is a public health campaign

More information

Sterile Product Preparation for Non-Pharmacy Personnel Dennis Sinclair, R.Ph..

Sterile Product Preparation for Non-Pharmacy Personnel Dennis Sinclair, R.Ph.. Sterile Product Preparation for Non-Pharmacy Personnel Dennis Sinclair, R.Ph.. Objectives Describe the importance of accuracy and use of proper aseptic technique when preparing IV medications. Identify

More information

Slide 1. Slide 2. Slide 3. What is injection safety Safe injection practices- Blood glucose monitoring Sharp safety.

Slide 1. Slide 2. Slide 3. What is injection safety Safe injection practices- Blood glucose monitoring Sharp safety. Slide 1 Safe Patient Care Keeping our Residents Safe Safe injection practices sharps management Fiona Barry 2016 at ALL times #safepatientcare Slide 2 Learning outcomes What is injection safety Safe injection

More information

6/7/2017 CHANGES IN PHARMA REGULATIONS HOW IT AFFECTS THE OR NURSE DISCLOSURE OBJECTIVES

6/7/2017 CHANGES IN PHARMA REGULATIONS HOW IT AFFECTS THE OR NURSE DISCLOSURE OBJECTIVES CHANGES IN PHARMA REGULATIONS HOW IT AFFECTS THE OR NURSE John Karwoski, RPh, MBA DISCLOSURE I, John Karwoski, RPH, MBA have business relationships with the companies MOBIUS THERAPEUTICS, LLC, Cubex, and

More information

SOURCES OF INFECTION IN LONG-TERM CARE FACILITY - ENVIRONMENTAL ISSUES

SOURCES OF INFECTION IN LONG-TERM CARE FACILITY - ENVIRONMENTAL ISSUES SOURCES OF INFECTION IN LONG-TERM CARE FACILITY - ENVIRONMENTAL ISSUES Slides provided by: William A. Rutala, PhD, MPH Director, Hospital Epidemiology, Occupational Health and Safety at UNC Health Care;

More information

OUTBREAKS AND SAFE INJECTION PRACTICES IN DENTAL SETTINGS OBJECTIVES

OUTBREAKS AND SAFE INJECTION PRACTICES IN DENTAL SETTINGS OBJECTIVES Module D OUTBREAKS AND SAFE INJECTION PRACTICES IN DENTAL SETTINGS OBJECTIVES 1. The Big Picture 2. Outbreaks and best practices 3. Beyond the outbreaks 4. Resources 1 THE BIG PICTURE THE BIG PICTURE 2

More information

Welcome to Section C, Outbreaks and Safe Injection Practices. This is the 3rd section of the state approved educational course required for

Welcome to Section C, Outbreaks and Safe Injection Practices. This is the 3rd section of the state approved educational course required for Welcome to Section C, Outbreaks and Safe Injection Practices. This is the 3rd section of the state approved educational course required for compliance with the NC Rule.0206 Infection Control in Health

More information

A "Never" Event: Unsafe Injection Practices

A Never Event: Unsafe Injection Practices A "Never" Event: Unsafe Injection Practices Joseph Perz DrPH MA Arjun Srinivasan MD Priti Patel MD MPH Prevention and Response Branch Division of Healthcare Quality Promotion Centers for Disease Control

More information

Drug Diversion and Safe Injections: Risks, Recommendations, & Resources. Oregon Public Health Division Healthcare-Associated Infections HAI Program

Drug Diversion and Safe Injections: Risks, Recommendations, & Resources. Oregon Public Health Division Healthcare-Associated Infections HAI Program Drug Diversion and Safe Injections: Risks, Recommendations, & Resources Oregon Public Health Division Healthcare-Associated Infections HAI Program Drug diversion can lead to infection Hepatitis C virus

More information

Single Dose Vial / Repackaging FactFinder

Single Dose Vial / Repackaging FactFinder Single Dose Vial / Repackaging FactFinder Committed to providing helpful information to International Spine Intervention Society members about key patient safety issues, the Society s Patient Safety Committee

More information

CDC s Position Protect Patients Against Preventable Harm from Improper Use of Single-dose/Single-use Vials

CDC s Position Protect Patients Against Preventable Harm from Improper Use of Single-dose/Single-use Vials Centers for Disease Control and Prevention National Center for Emerging and Zoonotic Infectious Diseases Division of Healthcare Quality Promotion Single-dose/Single-use Vial Position and Messages May 2,

More information

Reminders Regarding Unique and Overlooked Risks for Dental Services in Health Centers

Reminders Regarding Unique and Overlooked Risks for Dental Services in Health Centers Reminders Regarding Unique and Overlooked Risks for Dental Services in Health Centers Environment of Care The organization manages risks related to hazardous material and waste. (Standard EC 02.02.01/EPs

More information

THE BIG PICTURE. Outbreaks and Safe Injection Practices in outpatient Settings 9/11/2013. The Big Picture

THE BIG PICTURE. Outbreaks and Safe Injection Practices in outpatient Settings 9/11/2013. The Big Picture Module D Outline Outbreaks and Safe Injection Practices in outpatient Settings 1. The big picture 2. Outbreaks and best practices 3. Beyond the outbreaks 4. Resources THE BIG PICTURE The Big Picture Unsafe

More information

Healthcare-Related Outbreaks of Hepatitis B and C in the United States

Healthcare-Related Outbreaks of Hepatitis B and C in the United States Healthcare-Related Outbreaks of Hepatitis B and C in the United States Ian T. Williams, PhD, MS Epidemiology Branch Division of Viral Hepatitis National Center for Infectious Diseases Centers for Disease

More information

8/28/2014. Topics of Concern: Infection Control in LTC Settings in North Dakota. Bonnie M. Barnard, MPH, CIC

8/28/2014. Topics of Concern: Infection Control in LTC Settings in North Dakota. Bonnie M. Barnard, MPH, CIC Topics of Concern: Infection Control in LTC Settings in North Dakota Bonnie M. Barnard, MPH, CIC 1 Objectives List three mechanisms of transmission for bloodborne pathogens in long term care settings (Assisted)

More information

SUBJECT: Effective Date: Policy Number: Controlled Substance and Prescription Drugs 11/30/

SUBJECT: Effective Date: Policy Number: Controlled Substance and Prescription Drugs 11/30/ Division of Research SUBJECT: Effective Date: Controlled Substance and Prescription Drugs 11/30/2018 Supersedes: Page Of 12/04/2015 04/25/2007 1 6 Responsible Authorities: Vice President, Research Institutional

More information

Hepatitis C 02/20/2017. It does happen! Outbreaks

Hepatitis C 02/20/2017. It does happen! Outbreaks Hepatitis C STRATEGIES TO PREVENT SPREAD OF HEPATITIS C IN THE WORKPLACE NORMA GOMEZ, MBA, MSN, RN, CNE It does happen! "A recent publication describes a dialysis facility where an outbreak of HCV continued

More information

Guideline for the Rational Use of Controlled Drugs

Guideline for the Rational Use of Controlled Drugs Guideline for the Rational Use of Controlled Drugs Ministry of Health Male' Republic of Maldives April 2000 Table of Contents Page Introduction.. 2 1. Procurement and Supply of Controlled Drugs 3 1.1 Import

More information

THE BIG PICTURE. Outbreaks and Safe Injection Practices in outpatient Settings 9/11/2013. Outline. The Big Picture

THE BIG PICTURE. Outbreaks and Safe Injection Practices in outpatient Settings 9/11/2013. Outline. The Big Picture Module D Outbreaks and Safe Injection Practices in outpatient Settings Outline 1. The big picture 2. Outbreaks and best practices 3. Beyond the outbreaks 4. Resources THE BIG PICTURE The Big Picture 1

More information

UNIVERSITY POLICY. Revised: Contact:

UNIVERSITY POLICY. Revised: Contact: UNIVERSITY POLICY Policy Name: Policy for Controlled Substances Section #: 90.2.3 Section Title: Compliance Approval Authority: Responsible Executive: Responsible Office: Formerly Book: President Adopted:

More information

Infection Prevention and Control Annual Education Authored by: Infection Prevention and Control Department

Infection Prevention and Control Annual Education Authored by: Infection Prevention and Control Department Infection Prevention and Control Annual Education 2017 Authored by: Infection Prevention and Control Department Objectives After you complete this Computer-Based Learning (CBL) module, you should be able

More information

Crowe Healthcare Webinar Series

Crowe Healthcare Webinar Series Crowe Healthcare Webinar Series Healthcare Providers Ongoing Challenges With Controlled Substances Presented by: Scott Gerard, Healthcare Risk Consulting Partner Eric Jolly, Healthcare Risk Vice President

More information

History Note: Authority G.S ; ; ; Eff. May 1, 1997; Amended Eff. January 1, 2015; March 1, 2013.

History Note: Authority G.S ; ; ; Eff. May 1, 1997; Amended Eff. January 1, 2015; March 1, 2013. 21 NCAC 46.1412 PHYSICAL REQUIREMENTS A health care facility pharmacy shall have sufficient floor space allocated to it to ensure that drugs are prepared in sanitary, well lighted, and enclosed places.

More information

Infection Control for Anesthesia Personnel

Infection Control for Anesthesia Personnel Infection Control for Anesthesia Personnel 2017 A leading cause of death and increased morbidity for hospitalized ptns Hospitals, nursing homes, long-term care facilities, home care settings Higher rate

More information

Mass Dispensing Operations. Lou Ann Lance, RN, MSN Public Health Emergency Epidemiology New York State Department of Health

Mass Dispensing Operations. Lou Ann Lance, RN, MSN Public Health Emergency Epidemiology New York State Department of Health Mass Dispensing Operations Lou Ann Lance, RN, MSN Public Health Emergency Epidemiology New York State Department of Health November 1, 2013 Participants will: Objectives Understand procedures for cold

More information

Secure Medicine Return in King County, WA. Margaret Shield, Local Hazardous Waste Management Program in King County October 16, 2013

Secure Medicine Return in King County, WA. Margaret Shield, Local Hazardous Waste Management Program in King County October 16, 2013 Secure Medicine Return in King County, WA Margaret Shield, Local Hazardous Waste Management Program in King County October 16, 2013 1 Local Hazardous Waste Management Program in King County (LHWMP) Program

More information

Disclosure. Objectives. Objectives. Introduction. Introduction. Non-Sterile Compounding/Calculations

Disclosure. Objectives. Objectives. Introduction. Introduction. Non-Sterile Compounding/Calculations 49th Annual Meeting Non-Sterile Compounding/ Sunil Jambhekar, B. Pharm., M.S., Ph.D Professor, Pharmaceutical Sciences LECOM Bradenton, School of Pharmacy Bradenton, FL 34211 Disclosure I do not have a

More information

Outbreak Investigation Guidance for Healthcare-Associated Infections

Outbreak Investigation Guidance for Healthcare-Associated Infections COMMUNICABLE DISEASE OUTBREAK MANUAL New Jersey s Public Health Response APPENDIX T2: EXTENDED GUIDANCE Outbreak Investigation Guidance for Healthcare-Associated Infections CURRENT HAI CONTEXT AND GOALS

More information

Pharmacy Instructions for Preparation

Pharmacy Instructions for Preparation MARQIBO (vincristine sulfate LIPOSOME injection) Pharmacy Instructions for Preparation Important Information for Preparation 1 The instructions for the constitution of MARQIBO are provided in each kit.

More information

19/08/2014. What is Injection Safety?

19/08/2014. What is Injection Safety? Infection Prevention and Control A Foundation Course SAFE INJECTION PRACTICES AND SHARPS MANAGEMENT Fiona Barry IPCN Mercy University Hospital, Cork 2014 Links to CDC Materials http://www.youtube.com/watch%3fv%3d6d0stmoz80k

More information

SOP 17 BLOOD BANK. 3. Overall Responsibility: Blood Bank In-Change/Pathologist.

SOP 17 BLOOD BANK. 3. Overall Responsibility: Blood Bank In-Change/Pathologist. SOP 17 BLOOD BANK 1. Purpose: To ensure the availability of safe blood unit with facility for compatibility testing, storage and issue of blood in an aseptic environment on 24*7 basis trough trained professionals.

More information

New York State Vaccine Program Vaccine Restitution Policy

New York State Vaccine Program Vaccine Restitution Policy Purpose New York State (NYS) provides vaccine worth approximately $79 million to Vaccines for Children (VFC) providers in New York State (outside of New York City) each year at no cost to providers. As

More information

IMPAACT MOCHA More Options for Children and Adolescents

IMPAACT MOCHA More Options for Children and Adolescents IMPAACT 2017 Phase I/II Study of the Safety, Acceptability, Tolerability, and Pharmacokinetics of Oral and Long-Acting Injectable Cabotegravir and Long-Acting Injectable Rilpivirine in Virologically Suppressed

More information

AMBULANCE DECONTAMINATION GUIDELINES SUSPECTED INFLUENZA PATIENT

AMBULANCE DECONTAMINATION GUIDELINES SUSPECTED INFLUENZA PATIENT AMBULANCE DECONTAMINATION GUIDELINES SUSPECTED INFLUENZA PATIENT Reprinted with the Permission of John Hill, President Iowa EMS Association Following are general guidelines for cleaning or maintaining

More information

INJECTIONS WITHOUT INFECTIONS: SAFE INJECTION PRACTICES ONE NEEDLE, ONE SYRINGE, ONLY ONE TIME

INJECTIONS WITHOUT INFECTIONS: SAFE INJECTION PRACTICES ONE NEEDLE, ONE SYRINGE, ONLY ONE TIME INJECTIONS WITHOUT INFECTIONS: SAFE INJECTION PRACTICES ONE NEEDLE, ONE SYRINGE, ONLY ONE TIME Patsy Kelso, PhD State Epidemiologist for Infectious Disease Vermont Department of Health INJECTIONS & INFUSIONS

More information

Dental Legal Case Study

Dental Legal Case Study Risk Management Lessons for Dentists Infection Prevention Strategies Dentists Required to Comply with Regulations as a Condition of Licensure Chadwick v. Board of Registration in Dentistry, 461 Mass. 77;

More information

2008 ASHP Summer Meeting Seattle, Washington Educational Session Abstracts

2008 ASHP Summer Meeting Seattle, Washington Educational Session Abstracts 2008 ASHP Summer Meeting Seattle, Washington Educational Session Abstracts 116 USP Update 2008 and Personnel-Related Environmental Sampling Trissel, L.A. TriPharma Research, P.O. Box 265, Cashiers,

More information

3.0 POSITION ON PRE-LOADING SYRINGES WITH VACCINE

3.0 POSITION ON PRE-LOADING SYRINGES WITH VACCINE 1.0 PURPOSE 1.1 To provide guidance regarding the limited practice of pre-loading syringes with vaccine in controlled mass immunization settings as a part of a strategy to improve clinic efficiency while

More information

Dispensing and administration of emergency opioid antagonist without a

Dispensing and administration of emergency opioid antagonist without a 68-7-23. Dispensing and administration of emergency opioid antagonist without a prescription. (a) A pharmacist may dispense an FDA-approved emergency opioid antagonist and the necessary medical supplies

More information

1.40 Prevention of Nosocomial Pneumonia

1.40 Prevention of Nosocomial Pneumonia 1.40 Prevention of Nosocomial Pneumonia Purpose Audience Policy Statement: The guideline is designed to reduce the incidence of pneumonia and other acute lower respiratory tract infections. All UTMB healthcare

More information

Vial. A healthcare provider should show you how to inject MYALEPT before you use it for

Vial. A healthcare provider should show you how to inject MYALEPT before you use it for MYALEPT (metreleptin) for injection Instructions for Use MYALEPT (MAI-uh-lept) (metreleptin) for injection Vial A healthcare provider should show you how to inject MYALEPT before you use it for 8 Do not

More information

PATIENT SAFETY 101: PREVENTING INFECTIOUS DISEASE TRANSMISSION DURING BLOOD GLUCOSE MONITORING

PATIENT SAFETY 101: PREVENTING INFECTIOUS DISEASE TRANSMISSION DURING BLOOD GLUCOSE MONITORING PATIENT SAFETY 101: PREVENTING INFECTIOUS DISEASE TRANSMISSION DURING BLOOD GLUCOSE MONITORING Nicola Thompson, PhD & Melissa Schaefer, MD Division of Healthcare Quality Promotion, Centers for Disease

More information

A step-by-step preparation guide

A step-by-step preparation guide A step-by-step preparation guide For needle and needle-free systems This guide provides detailed instructions on the reconstitution, dilution, and storage of VELETRI. It is intended to be used after your

More information

Toronto Public Health HCV Outbreak Investigation Ontario Endoscopy Clinic 1315 Finch Avenue West, Suite 302, Toronto Final Report April 24, 2015

Toronto Public Health HCV Outbreak Investigation Ontario Endoscopy Clinic 1315 Finch Avenue West, Suite 302, Toronto Final Report April 24, 2015 Toronto Public Health HCV Outbreak Investigation Ontario Endoscopy Clinic 1315 Finch Avenue West, Suite 302, Toronto Final Report April 24, 2015 Initial Case Identification On May 24, 2013, a 60 year old

More information

A step-by-step preparation guide

A step-by-step preparation guide A step-by-step preparation guide This guide provides detailed instruction on the reconstitution, dilution, and storage of Veletri (epoprostenol) for Injection. It is intended to be used after your healthcare

More information

MYALEPT (MAI-uh-lept) (metreleptin) for injection for subcutaneous use

MYALEPT (MAI-uh-lept) (metreleptin) for injection for subcutaneous use .3 mg per vial _ A healthcare provider should show you how to inject MYALEPT before you use it for the first time. A healthcare provider should also watch you inject your MYALEPT dose the first time you

More information

Toronto Public Health HCV Outbreak Investigation Downsview Endoscopy Clinic 968 Wilson Avenue, Toronto Final Report October 6, 2014

Toronto Public Health HCV Outbreak Investigation Downsview Endoscopy Clinic 968 Wilson Avenue, Toronto Final Report October 6, 2014 Toronto Public Health HCV Outbreak Investigation Downsview Endoscopy Clinic 968 Wilson Avenue, Toronto Final Report October 6, 2014 Initial Case Identification On June 6, 2013, a 58 year old male (Case

More information

Template Standard Operating Procedure For: Handling of Midazolam and other controlled drugs in Dental Practices

Template Standard Operating Procedure For: Handling of Midazolam and other controlled drugs in Dental Practices Name of Dental Practice : Objectives To ensure implementation of the regulations and guidance on safe and secure handling of midazolam and other controlled drugs (CDs) Scope To cover all aspects of obtaining

More information

Preventing Transmission of Bloodborne Pathogens in Healthcare Settings

Preventing Transmission of Bloodborne Pathogens in Healthcare Settings Preventing Transmission of Bloodborne Pathogens in Healthcare Settings Joshua K. Schaffzin, MD, PhD Healthcare Epidemiology and Infection Control Program Bureau of Healthcare Associated Infections Outline

More information

Ingredient Listing Qty. Unit NDC # Supplier. q.s. to ml

Ingredient Listing Qty. Unit NDC # Supplier. q.s. to ml 12/20/2018; Page 1 SUGGESTED FORMULATION Ingredient Listing Qty. Unit NDC # Supplier, USP 10 MU Sucrose, NF 23.00 g Propylene Glycol, USP 7.0 ml Medisca Oral Mix (Flavored Suspending Vehicle) 50.0 ml Medisca

More information

9/3/2013. Presentation Objective. Prescription Drug Abuse Statistics Prescription Drug Abuse Statistics. Pharmaceutical Drugs and the Environment

9/3/2013. Presentation Objective. Prescription Drug Abuse Statistics Prescription Drug Abuse Statistics. Pharmaceutical Drugs and the Environment Presentation Objective Background - Why do we need a regulation for the disposal of controlled substances. Disposal of Controlled Substances DEA Notice of Proposed Rulemaking AHMP 2013 National Conference

More information

Infection Prevention and Control - General Orientation

Infection Prevention and Control - General Orientation Infection Prevention and Control - General Orientation Hand Hygiene-CDC Isolation Precautions - CDC Medical Waste - OSHA Environmental Cleaning - CDC Safe Injection Practices - CDC Bloodborne Pathogens

More information

Infection Control Assessment and Response (ICAR) in Long-term Care

Infection Control Assessment and Response (ICAR) in Long-term Care Infection Control Assessment and Response (ICAR) in Long-term Care Carol Genese, MBA ICAR Infection Preventionist Communicable Disease Service New Jersey Department of Health Agenda ICAR Introduction ICAR

More information

The pages that follow contain information critical to protecting the health of your patients and the citizens of Colorado.

The pages that follow contain information critical to protecting the health of your patients and the citizens of Colorado. Health Alert Network Tri-County Health Department Serving Adams, Arapahoe and Douglas Counties Phone 303/220-9200 Fax 303/741-4173 www.tchd.org Richard L. Vogt, M.D. Executive Director The pages that follow

More information

Injection Safety! Every Providerʼs Responsibility!

Injection Safety! Every Providerʼs Responsibility! Injection Safety! Every Providerʼs Responsibility! Outline! Safe Injection Practices" The ONE and ONLY Campaign" Outbreak History" Mistaken Beliefs" A Call to Action" Resources and Information" Why Unsafe

More information

Louisiana. Prescribing and Dispensing Profile. Research current through November 2015.

Louisiana. Prescribing and Dispensing Profile. Research current through November 2015. Prescribing and Dispensing Profile Louisiana Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points

More information

CBIA e 2 Waste Task Force Summary January 18, 2019

CBIA e 2 Waste Task Force Summary January 18, 2019 DEEP - - Cleanup Transformation DEEP - - Spill Reporting RSR Wave 2 Roll Out: Wave 2 proposed regulations remain under legal and management review and revision at DEEP. Once internal management review

More information

2018 CDC VFC Compliance Visit Requirements & Recommendations

2018 CDC VFC Compliance Visit Requirements & Recommendations 2018 CDC VFC Compliance Visit Requirements & Recommendations ELIGIBILITY & DOCUMENTATION Changes to Key Staff All changes in key staff must be communicated to the Immunization Program in the manner and

More information

Immunization Best Practices and Influenza Vaccines

Immunization Best Practices and Influenza Vaccines Immunization Best Practices and Influenza Vaccines JoEllen Wolicki, BSN, RN Nurse Educator Communications Education Partnership Branch National Center for Immunization and Respiratory Diseases Immunization

More information

Tube feeding with a nasogastric or nasojejunal tube

Tube feeding with a nasogastric or nasojejunal tube Tube feeding with a nasogastric or nasojejunal This factsheet tells you how to care for your feeding and how to take your feed and medications via your. Your dietitian needs to fill in parts of this factsheet.

More information

Tool B Facilities, Supplies & Equipment

Tool B Facilities, Supplies & Equipment Tool B Facilities, Supplies & Equipment Voluntary Medical Male Circumcision (VMMC) Tool B Facilities, Supplies & Equipment External Quality Assurance (EQA) Site Name: Reviewer s Name: Date: This Tool (B)

More information

Policy Guide Injectable Hydromorphone Maintenance Treatment (2018)

Policy Guide Injectable Hydromorphone Maintenance Treatment (2018) Professional Practice Policy #67 Policy Guide Injectable Hydromorphone Maintenance Treatment (2018) P2 Injectable Hydromorphone Maintenance Treatment Policy Guide All pharmacy managers, staff pharmacists,

More information

Safe Medication Disposal A white position paper Pennsylvania Pharmacists Association February 8, 2009

Safe Medication Disposal A white position paper Pennsylvania Pharmacists Association February 8, 2009 Safe Medication Disposal A white position paper Pennsylvania Pharmacists Association February 8, 2009 Background and Situation Analysis: Consumers are rightly confused about what to do with their unwanted

More information

Ingredient Listing Qty. Unit NDC # Supplier g

Ingredient Listing Qty. Unit NDC # Supplier g 8/16/2018; Page 1 SUGGESTED FORMULATION Ingredient Listing Qty. Unit NDC # Supplier Lidocaine, USP 0.400 g Stevia Powder 0.10 g Polyox TM WSR-301 Topical Adhesive Powder* 9.50 g *Formula # F 007 422 available

More information

Policy Title: Single-Use (Disposable) Devices Policy Number: 13. Effective Date: 6/10/2013 Review Date: 6/10/2016

Policy Title: Single-Use (Disposable) Devices Policy Number: 13. Effective Date: 6/10/2013 Review Date: 6/10/2016 Policy Title: Single-Use (Disposable) Devices Policy Number: 13 5. ROLES AND RESPONSIBILITIES: 5.1. All dental healthcare personnel have responsibility to conform and respect all aspects of this policy.

More information

Doc No: BLOOD Midland Engineering Co., Inc. Initial Issue Date 12/04/15 Safety Management System

Doc No: BLOOD Midland Engineering Co., Inc. Initial Issue Date 12/04/15 Safety Management System Revision Preparation: Safety Mgr Authority: President Issuing Dept: Safety Page: Page 1 of 15 INTRODUCTION The Occupational Safety and Health Administration (OSHA) has a variety of regulations that all

More information

Safe Disposal of Unneeded Medications

Safe Disposal of Unneeded Medications Safe Disposal of Unneeded Medications Lesson created by: Marilyn Sink Molly Marshall Health & Human Sciences Educator/CED Health & Human Sciences Educator Clark County, Area 2 Jackson County, Area 2 msink@purdue.edu

More information

SANTA BARBARA COUNTY DEPARTMENT OF Behavioral Wellness A System of Care and Recovery

SANTA BARBARA COUNTY DEPARTMENT OF Behavioral Wellness A System of Care and Recovery Section Sub-section Policy Policy# Pharmacy SANTA BARBARA COUNTY DEPARTMENT OF Behavioral Wellness A System of Care and Recovery Pyxis MedStation Controlled Substances 17.102 Page 11 of 5 Programmatic

More information

Hazardous Materials Medication Box and Exchange Procedure

Hazardous Materials Medication Box and Exchange Procedure September 2012 Page 1 of 6 Hazardous Materials Medication Box and Exchange Procedure EMS Service Stock 1. Each EMS Agency will be responsible for the security and storage of the supply of hazardous material

More information

Hazardous Materials Medication Box and Exchange Procedure

Hazardous Materials Medication Box and Exchange Procedure May 2017 Page 1 of 5 Hazardous Materials Medication Box and Exchange Procedure EMS Service Stock 1. Each EMS Agency will be responsible for the security and storage of the supply of hazardous material

More information

Hepatitis B and C Overview, Outbreaks, and Recommendations. Viral Hepatitis Language. Types of Viral Hepatitis 7/1/2013

Hepatitis B and C Overview, Outbreaks, and Recommendations. Viral Hepatitis Language. Types of Viral Hepatitis 7/1/2013 Hepatitis B and C Overview, Outbreaks, and Recommendations Elizabeth Lawlor, MS Healthy Kansans living in safe and sustainable environments. Viral Hepatitis Language Acute infection is when the infection

More information

Ambulatory Surgery Outbreaks, Los Angeles County. Kelsey OYong, MPH Acute Communicable Disease Control Program June 3, 2016

Ambulatory Surgery Outbreaks, Los Angeles County. Kelsey OYong, MPH Acute Communicable Disease Control Program June 3, 2016 Ambulatory Surgery Outbreaks, Los Angeles County Kelsey OYong, MPH Acute Communicable Disease Control Program June 3, 2016 Objectives Review recent outbreaks in ambulatory surgery centers (ASCs) Describe

More information

PROCEDURE. TITLE: Bedside Glucose Monitoring PC Laboratory. Issuing Department: Clinical Director Signature: Departments Involved:

PROCEDURE. TITLE: Bedside Glucose Monitoring PC Laboratory. Issuing Department: Clinical Director Signature: Departments Involved: PROCEDURE TITLE: Bedside Glucose Monitoring Issuing Department: Clinical Director Signature: Departments Involved: Laboratory Nursing Effective Date: 10/97 Review Dates: 09/01, 07/02, 05/13 Revision Dates:

More information

OBJECTIVES PEOPLE AS RESERVOIRS. Reservoir

OBJECTIVES PEOPLE AS RESERVOIRS. Reservoir Module C EPIDEMIOLOGY AND RISK OF INFECTION IN OUTPATIENT SETTINGS Statewide Program for Infection Control and Epidemiology (SPICE) UNC School of Medicine OBJECTIVES Discuss the infectious process Review

More information

Anne Carbonne Regional center for nosocomial infection control, Paris

Anne Carbonne Regional center for nosocomial infection control, Paris Nosocomial HCV infections Anne Carbonne Regional center for nosocomial infection control, Paris HCV transmission in health care settings Patient 1 Blood exposure or Invasive procedure Patient 2 Health

More information

Being Smart About Your Medicines What you need to know to make sure your medicines are helping, not hurting

Being Smart About Your Medicines What you need to know to make sure your medicines are helping, not hurting Being Smart About Your Medicines What you need to know to make sure your medicines are helping, not hurting Danielle Fixen, PharmD, BCGP, BCPS Assistant Professor, Department of Clinical Pharmacy Skaggs

More information

CATHETER ACCESS KIT. For use with Prometra Programmable Infusion Systems

CATHETER ACCESS KIT. For use with Prometra Programmable Infusion Systems CATHETER ACCESS KIT Caution: Federal (USA) Law restricts this device to sale by or on the order of a physician. Table of Contents Contents... 3 Description... 3 Indications... 3 Contraindications... 3

More information

LEARNING MODULE: INFECTION CONTROL BLOODBORNE PATHOGENS ISOLATION PRECAUTIONS PHARMACEUTICAL WASTE

LEARNING MODULE: INFECTION CONTROL BLOODBORNE PATHOGENS ISOLATION PRECAUTIONS PHARMACEUTICAL WASTE LEARNING MODULE: INFECTION CONTROL BLOODBORNE PATHOGENS ISOLATION PRECAUTIONS PHARMACEUTICAL WASTE For Residents & Instructors ggbha.org Updated 6/18/2018 This learning module must be reviewed by residents

More information

Contrast Media Guidelines. To define general guidelines for the use of contrast media so that it is used appropriately and safely in imaging studies.

Contrast Media Guidelines. To define general guidelines for the use of contrast media so that it is used appropriately and safely in imaging studies. APPROVED BY: Director of Radiology Page 1 of 6 Purpose: Contrast Media Guidelines To define general guidelines for the use of contrast media so that it is used appropriately and safely in imaging studies.

More information

Optimal nutrition in critically ill children

Optimal nutrition in critically ill children Optimal nutrition in critically ill children MODULE 4 Good safety practices required for nutritional therapy Developed by The Asia Pacific Middle East Consensus Working Group on Nutrition Therapy in the

More information

Joint Commission In Dental Settings

Joint Commission In Dental Settings Joint Commission In Dental Settings Jay Afrow DMD, MHA Surveyor, Ambulatory Health Care The Joint Commission The Joint Commission Disclaimer These slides are current as of 1/19/2018. The Joint Commission

More information

7/27/2017. Reducing HAI Risk through Safe Injection Practices. Disclosures. Learning Objectives. Presenter provides consulting services to J&J Ethicon

7/27/2017. Reducing HAI Risk through Safe Injection Practices. Disclosures. Learning Objectives. Presenter provides consulting services to J&J Ethicon Reducing HAI Risk through Safe Injection Practices Presenter: Sue Barnes, RN, CIC, FAPIC Independent Clinical Consultant sueabarnes@gmail.com Disclosures Presenter provides consulting services to J&J Ethicon

More information

ZADITEN Eye Drops 1.0%

ZADITEN Eye Drops 1.0% ZADITEN Eye Drops 1.0% Ketotifen Consumer Medicine Information What is in this leaflet Please read this leaflet carefully before you use Zaditen Eye Drops. This leaflet answers some common questions about

More information

MODULE B. Objectives. Infection Prevention. Infection Prevention. N.C. Nurse Aide I Curriculum

MODULE B. Objectives. Infection Prevention. Infection Prevention. N.C. Nurse Aide I Curriculum DHSR/HCPR/CARE NAT I Curriculum - July 2013 1 N.C. Nurse Aide I Curriculum MODULE B Infection Prevention Objectives Relate the chain of infection to the work of a nurse aide in long-term care facilities.

More information

I want to make sure I am ready for flu season. I want to be protected and prepared.

I want to make sure I am ready for flu season. I want to be protected and prepared. Cold and Flu I want to make sure I am ready for flu season. I want to be protected and prepared. uprevent.mckesson.com/flu-prevention MUST-HAVES: Test Prep Inject Protect! Table Paper Tongue Blades Paper,

More information

If viewing a printed copy of this policy, please note it could be expired. Got to to view current policies.

If viewing a printed copy of this policy, please note it could be expired. Got to  to view current policies. If viewing a printed copy of this policy, please note it could be expired. Got to www.fairview.org/fhipolicies to view current policies. Department Policy Code: D: PC-5575 Entity: Fairview Pharmacy Services

More information

Epidemiology and Risk of Infection in outpatient Settings

Epidemiology and Risk of Infection in outpatient Settings Module C Epidemiology and Risk of Infection in outpatient Settings Statewide Program for Infection Control and Epidemiology (SPICE) UNC School of Medicine Objectives Discuss the infectious process through

More information

Epidemiology and Risk of Infection in outpatient Settings

Epidemiology and Risk of Infection in outpatient Settings Module C Epidemiology and Risk of Infection in outpatient Settings Statewide Program for Infection Control and Epidemiology (SPICE) UNC School of Medicine Objectives Discuss the infectious process through

More information

SUBJECT: Management of Human Body Fluids/Waste (Bloodborne Pathogens)

SUBJECT: Management of Human Body Fluids/Waste (Bloodborne Pathogens) Page 1 of 6 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 PURPOSE To establish uniform procedures for the safe management of human body fluids

More information

EPIDEMIOLOGY AND RISK OF INFECTION IN DENTAL SETTINGS

EPIDEMIOLOGY AND RISK OF INFECTION IN DENTAL SETTINGS Module C EPIDEMIOLOGY AND RISK OF INFECTION IN DENTAL SETTINGS Statewide Program for Infection Control and Epidemiology (SPICE) OBJECTIVES Discuss the infectious process through review of the chain of

More information

Help Prevent Medication Errors with PDC Healthcare s Anesthesia Labels & Tapes

Help Prevent Medication Errors with PDC Healthcare s Anesthesia Labels & Tapes Help Prevent Medication Errors with PDC Healthcare s Anesthesia Labels & Tapes Where positive identification meets safe, efficient patient care. Improve Patient Safety with Accurate Medication Labeling

More information

Infection Control Sec. 1, Unit 5 Part 1

Infection Control Sec. 1, Unit 5 Part 1 Infection Control Sec. 1, Unit 5 Part 1 Introduction Infections are a significant cause of illness, disease and death for residents that reside in certain living situations including nursing facilities.

More information

Infection Control 2.5 Contact Hours Presented by: CEU Professor

Infection Control 2.5 Contact Hours Presented by: CEU Professor Infection Control 2.5 Contact Hours Presented by: CEU Professor www.ceuprofessoronline.com Copyright 2009 The Magellan Group, LLC. All Rights Reserved. Reproduction and distribution of these materials

More information

Petition 2014/15 of Anthony Roberts and 40 others

Petition 2014/15 of Anthony Roberts and 40 others Petition 2014/15 of Anthony Roberts and 40 others Report of the Health Committee Contents Recommendation 2 Background 2 The petitioner s concerns 3 Best practice and international benchmarks 4 Ministry

More information